340 related articles for article (PubMed ID: 23629625)
1. SAD-A potentiates glucose-stimulated insulin secretion as a mediator of glucagon-like peptide 1 response in pancreatic β cells.
Nie J; Lilley BN; Pan YA; Faruque O; Liu X; Zhang W; Sanes JR; Han X; Shi Y
Mol Cell Biol; 2013 Jul; 33(13):2527-34. PubMed ID: 23629625
[TBL] [Abstract][Full Text] [Related]
2. SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet β Cells.
Nie J; Sun C; Chang Z; Musi N; Shi Y
Endocrinology; 2018 Aug; 159(8):3036-3047. PubMed ID: 29873699
[TBL] [Abstract][Full Text] [Related]
3. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
[TBL] [Abstract][Full Text] [Related]
4. Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.
Nie J; Sun C; Faruque O; Ye G; Li J; Liang Q; Chang Z; Yang W; Han X; Shi Y
J Biol Chem; 2012 Jul; 287(31):26435-44. PubMed ID: 22669945
[TBL] [Abstract][Full Text] [Related]
5. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
6. Palmitic acid acutely inhibits acetylcholine- but not GLP-1-stimulated insulin secretion in mouse pancreatic islets.
Doliba NM; Qin W; Vinogradov SA; Wilson DF; Matschinsky FM
Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E475-85. PubMed ID: 20606076
[TBL] [Abstract][Full Text] [Related]
7. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
Liu L; Wang F; Lu H; Ren X; Zou J
Islets; 2014; 6(4):e962386. PubMed ID: 25437377
[TBL] [Abstract][Full Text] [Related]
8. Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1.
Peyot ML; Nolan CJ; Soni K; Joly E; Lussier R; Corkey BE; Wang SP; Mitchell GA; Prentki M
Diabetes; 2004 Jul; 53(7):1733-42. PubMed ID: 15220197
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
[TBL] [Abstract][Full Text] [Related]
10. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y
Cells; 2021 Sep; 10(9):. PubMed ID: 34572144
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
[TBL] [Abstract][Full Text] [Related]
12. SAD-A, a downstream mediator of GLP-1 signaling, promotes the phosphorylation of Bad S155 to regulate in vitro β-cell functions.
Wang K; Liu D; Zhang Y; Chang X; Xu R; Pang J; Li K; Sun P; Zhu Y; Han X
Biochem Biophys Res Commun; 2019 Jan; 509(1):76-81. PubMed ID: 30573363
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells.
Peyot ML; Gray JP; Lamontagne J; Smith PJ; Holz GG; Madiraju SR; Prentki M; Heart E
PLoS One; 2009 Jul; 4(7):e6221. PubMed ID: 19593440
[TBL] [Abstract][Full Text] [Related]
14. SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling.
Nie J; Liu X; Lilley BN; Zhang H; Pan YA; Kimball SR; Zhang J; Zhang W; Wang L; Jefferson LS; Sanes JR; Han X; Shi Y
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13857-62. PubMed ID: 23922392
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
16. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
Laychock SG
Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
[TBL] [Abstract][Full Text] [Related]
17. Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1.
Jacobo SM; Guerra ML; Hockerman GH
J Pharmacol Exp Ther; 2009 Nov; 331(2):724-32. PubMed ID: 19710366
[TBL] [Abstract][Full Text] [Related]
18. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
Hui H; Yu R; Bousquet C; Perfetti R
Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
[TBL] [Abstract][Full Text] [Related]
19. Snapin mediates incretin action and augments glucose-dependent insulin secretion.
Song WJ; Seshadri M; Ashraf U; Mdluli T; Mondal P; Keil M; Azevedo M; Kirschner LS; Stratakis CA; Hussain MA
Cell Metab; 2011 Mar; 13(3):308-19. PubMed ID: 21356520
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion.
Yan S; Conley JM; Reilly AM; Stull ND; Abhyankar SD; Ericsson AC; Kono T; Molosh AI; Kubal CA; Evans-Molina C; Ren H
Cell Rep; 2022 Jan; 38(1):110179. PubMed ID: 34986353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
